debate: which is the optimal approach for cll? - fcr
Published 10 years ago • 183 plays • Length 14:21Download video MP4
Download video MP3
Similar videos
-
12:08
debate: which is the optimal approach for cll? - br
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
14:02
debate: best frontline regimen for a cll patient aged 60 who requires therapy - fcr
-
15:23
debate: optimal approach for the management of cll patients with del(17p) - ibrutinib
-
11:23
debate: best approach for multiple relapsed cll after chemoimmunotherapy - kinase inhibitor
-
13:19
ighv and tp53 sequencing: clinical utility in chronic lymphocytic leukemia (cll)
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
1:05:51
update on chronic lymphocytic leukemia/small lymphocytic lymphoma | lrf webinars
-
21:05
cll: optimal approaches for patients with deletion 17p
-
14:48
debate: best frontline regimen for a cll patient aged 60 who requires therapy - ibrutinib
-
34:10
optimizing health outcomes through dietary choices for cancer prevention and management
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
12:34
debate: is it appropriate to treat patients with cll earlier in the era of novel agents? - no
-
19:40
key insights in chronic lymphocytic leukemia
-
19:14
debate: best approach for multiple relapsed cll after chemoimmunotherapy - other novel agents
-
30:55
immune function in cll: what is wrong and why?
-
2:01
fcr or fr – which regimen is better for treating cll?
-
14:34
debate: which initial therapy for younger fit patients is best? - cybord and bird
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
1:44
ibrutinib and fcr in cll irrespective of ighv mutation status
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
49:01
chronic lymphocytic leukemia: case discussions